<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A non-arteritic anterior ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> has usually a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>Spontaneous remissions are extremely rare </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast to arteritic anterior <z:e sem="disease" ids="C0238309" disease_type="Disease or Syndrome" abbrv="">ischemic neuropathy</z:e>, systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> are generally accepted to be ineffective </plain></SENT>
<SENT sid="3" pm="."><plain>Two cases of bilateral severe non-arteritic anterior ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> are reported who underwent full remission of their visual function directly related to high-dose systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>It is hypothesized that, in <z:hpo ids='HP_0011009'>acute</z:hpo> phases of non-arteritic anterior ischemic <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> a significant reduction of tissue swelling and consecutive prelaminar reperfusion can be achieved with high-dose <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
</text></document>